Compare Abbott Laboratories (ABT) vs Global X CleanTech (CTEC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Global X CleanTech — how do they compare? Abbott Laboratories trades at $95.2 (market cap $166.94B), while Global X CleanTech trades at $58. The key difference: Abbott Laboratories pays a 2.63% dividend while Global X CleanTech pays none, and Global X CleanTech is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | CTEC | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Sector/Thematic |
52-Week High | $136.62 | $78.11 |
52-Week Low | $82.57 | $38.45 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
CTEC trades at $62.95, up 2.15% today, but technical indicators show a bearish trend with moving averages signaling caution. The stock faces resistance near $63 with support at $61. Recent news highlights Deutsche Bank maintaining a buy rating ahead of the company's Capital Markets Day, viewing it as a credibility test for growth targets. Financial ratios remain undisclosed in current data.
The outlook hinges on execution of growth targets, with potential upside if management delivers on guidance. Risks include competitive pressures and market volatility. Analyst optimism exists, but investors need confirmation of fundamental improvements during upcoming corporate events to drive sustained price appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →
